Roivant Sciences Ltd (ROIV) Stock Analysis

Roivant Sciences Ltd (ROIV) is a publicly traded company in the HEALTHCARE sector. It trades at $28.25, carries a market capitalization of $21.08B. This page summarizes the public market data, fundamentals, and frequently asked questions for ROIV, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $28.25
• Market Cap: $21.08B
• EPS: $-0.54
• 52-Week High: $32.79
• 52-Week Low: $10.71

Market Sentiment

Roivant Sciences Ltd currently has a Bullish sentiment score of 0.27.

About Roivant Sciences Ltd

None

GNG Research Analysis

GNG Research scores Roivant Sciences Ltd (ROIV) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for ROIV.

Frequently Asked Questions

Does ROIV pay dividends?

Roivant Sciences Ltd (ROIV) does not currently pay a regular dividend.

What is ROIV's market cap?

Roivant Sciences Ltd (ROIV) has a market capitalization of $21.08B with a current stock price of $28.25.